Compare Transpek Inds. with Similar Stocks
Dashboard
Poor long term growth as Net Sales has grown by an annual rate of 9.85% and Operating profit at 9.21% over the last 5 years
Negative results in Jun 26
With ROE of 5.9, it has a Very Expensive valuation with a 1 Price to Book Value
Falling Participation by Institutional Investors
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Commodity Chemicals
INR 760 Cr (Micro Cap)
19.00
13
1.47%
-0.07
5.95%
0.99
Total Returns (Price + Dividend) 
Latest dividend: 20.120911938232936 per share ex-dividend date: Sep-07-2026
Risk Adjusted Returns v/s 
Returns Beta
News

Transpek Industry Ltd Technical Momentum Shifts Amid Mixed Market Returns
Transpek Industry Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a recent day decline of 2.09%, the stock’s technical indicators reveal a complex interplay of signals that investors should carefully analyse amid its micro-cap status and a recent downgrade in its Mojo Grade to Sell.
Read full news article
Transpek Industry Ltd Downgraded to Sell Amid Weak Financials and Technical Signals
Transpek Industry Ltd, a micro-cap player in the commodity chemicals sector, has seen its investment rating downgraded from Hold to Sell by MarketsMOJO as of 7 September 2026. This change reflects a combination of deteriorating technical indicators, subdued financial trends, expensive valuation metrics, and declining quality scores, signalling caution for investors amid a challenging market environment.
Read full news article
Transpek Industry Ltd Technical Momentum Shifts Amid Mixed Market Signals
Transpek Industry Ltd, a micro-cap player in the commodity chemicals sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock's technical indicators present a complex picture that investors should carefully analyse amid broader market volatility.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Credit Rating
01-Sep-2026 | Source : BSEIntimation of Credit Ratings
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
26-Aug-2026 | Source : BSEIntimation of Investor Group Meeting
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
25-Aug-2026 | Source : BSEIntimation of Transcript of Business Call dated 20.08.2026.
Corporate Actions 
No Upcoming Board Meetings
Transpek Industry Ltd has declared 200% dividend, ex-date: 07 Sep 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 1 FIIs (0.02%)
Anshul Specialty Molecules Private Limited (24.64%)
Mukul Mahavir Agrawal (2.12%)
31.99%
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is 1.92% vs -6.47% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is 35.71% vs -39.35% in Mar 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -0.02% vs 11.11% in Sep 2024
Growth in half year ended Sep 2025 is 49.79% vs 0.00% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -2.40% vs 12.33% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 32.49% vs -10.42% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -4.41% vs 12.11% in Mar 2025
YoY Growth in year ended Mar 2026 is -6.34% vs 26.40% in Mar 2025






